[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
September 8, 1999

Sildenafil for Diabetic Men With Erectile Dysfunction

Author Affiliations
 

Margaret AWinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;282(10):939-941. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-10-jbk0908

To the Editor: The clinical trial by Rendell et al1 designed to test whether sildenafil is a safe and effective treatment for ED in men with diabetes used the following inclusion, and by inference, exclusion criteria: "The patients also had to be in a stable relationship with a female partner for at least the previous 6 months [emphasis added]." The inclusion and exclusion criteria of a clinical trial determine not only who has access to a clinical trial, and therefore to a promising new therapy, but the generalizability of the trial's results.2 Therefore, it is essential to consider why the investigators required that the man's partner be female, and not simply male or female.

First Page Preview View Large
First page PDF preview
First page PDF preview
×